Dofort Pharma Private Limited

Dofort Pharma Private Limited - financial services in Ahmedabad, Gujarat, India. FY 2026 financials & compliance.
CIN U24232GJ2006PTC049026 Incorporated 06 September 2006 ROC Ahmedabad HQ Ahmedabad, Gujarat, India
Active Private Limited Company financial services
Revenue · FY 2025
₹72.85 Lakh
▲ 7% YoY
Net profit · FY 2025
₹17.96 Lakh
Net margin 24.6%
EBITDA · FY 2025
₹52.2 Lakh
EBITDA margin 71.6%
Authorised capital
₹1.8 Cr
Registered with MCA
Paid-up capital
₹12.39 Lakh
Issued & subscribed
Company age
20 yrs
Est. 2006
Directors on board
5
As per MCA filings
Active GSTINs
1
GST registered

About Dofort Pharma Private Limited

Data last updated:

Dofort Pharma Private Limited is a private limited company based in Ahmedabad, Gujarat, India. It operates in the real estate financing segment of the financial services sector. It was incorporated on 06 September 2006 and has been in existence for over 20 years.

The company is registered with the Registrar of Companies (ROC), Ahmedabad, under CIN U24232GJ2006PTC049026. Its GSTIN is 24AACCD4342D1Z8 (Gujarat).

The company has an authorised share capital of ₹1.8 Cr and a paid-up capital of ₹12.39 Lakh. It was formerly known as Day Lewis Chemist Pvt. Ltd. It is led by directors including Rajan Priyakant Parikh and Jayantilal Patel.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 501 5th Floor H. K. House Ashram Road Navrangpura, Ahmedabad, Gujarat, India – 380009.

As per the financials filed for FY 2025, the company reported a revenue of ₹72.85 Lakh, a growth of 7% compared to the previous year. For the same year it recorded a net profit of ₹17.96 Lakh (net margin 24.6%) and EBITDA of ₹52.2 Lakh (EBITDA margin 71.6%). Revenue has grown at a compounded annual rate (CAGR) of 6% over three years and 5% over five years.

The current compliance status is marked as compliant by the Registrar of Companies.

Company details

CIN U24232GJ2006PTC049026
Registration Number 049026
Incorporation Date 06 September 2006
ROC Ahmedabad
Listing Status Unlisted
Company Status Active
Compliance Status Active Compliant

Contact details

Dofort Pharma Private Limited's registered office is in Ahmedabad, Gujarat. Its e-mail address and telephone number are in the company report.

  • Email
  • Telephone
  • Registered Address
    501 5th Floor H. K. House Ashram Road Navrangpura, Ahmedabad, Gujarat, India – 380009
  • Industry
    Financial Services, Real Estate Financing

To see the full contact details of Dofort Pharma Private Limited, buy the company report.

Comprehensive company report
Dofort Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Financials of Dofort Pharma Private Limited

FY 2025 filings available

Dofort Pharma Private Limited reported revenue of ₹72.85 Lakh (up 7% YoY) for FY 2025.

Revenue · FY 2025
₹72.85 Lakh ▲ 7%
Net profit · FY 2025
₹17.96 Lakh margin 24.6%
EBITDA · FY 2025
₹52.2 Lakh margin 71.6%

Compounded Annual Growth Rate (CAGR)

Revenue CAGR growth
1 year
▲ 7%
3 years · compounded
▲ 6%
5 years · compounded
▲ 5%
EBITDA CAGR growth
1 year
▼ 19%
3 years · compounded
▼ 3%

Revenue has grown at a compounded annual rate (CAGR) of 5% over five years, including 7% growth in the latest year. EBITDA fell 19% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.

Financial Statement Summary

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profit and Loss Statement
Revenue from Operations
Other Income
Total Revenue
Cost of Materials Consumed
Employee Benefit Expense
Finance Costs
Depreciation and Amortisation
Other Expenses
Total Expenses
EBITDA₹52.2 Lakh
Profit Before Tax
Tax Expense
Net Profit (PAT)₹17.96 Lakh
Balance Sheet
Share Capital
Reserves and Surplus
Net Worth (Total Equity)
Long-term Borrowings
Short-term Borrowings
Trade Payables
Total Liabilities
Fixed Assets
Investments
Inventories
Trade Receivables
Cash and Bank Balance
Total Assets

Financial Ratios

MetricsFY 2024-25FY 2023-24FY 2022-23FY 2021-22FY 2020-21
Profitability
EBITDA Margin71.6%
Net Profit Margin24.6%
Return on Equity (ROE)
Return on Capital Employed (ROCE)
Return on Assets (ROA)
Liquidity and Debt
Current Ratio
Quick Ratio
Debt-to-Equity Ratio
Interest Coverage Ratio
Efficiency and Growth
Asset Turnover
Receivable Days
Payable Days
Inventory Days
Revenue Growth
Net Profit Growth

To see the full financial statements and ratios of Dofort Pharma Private Limited, buy the company report.

Board of directors of Dofort Pharma Private Limited

Dofort Pharma has 5 current directors and 7 former directors. Current directors are listed first, with their designation and appointment date.

Current Directors
NameDesignationAppointment DateTenureStatus
Rajan Priyakant ParikhDirector07 Oct 20197 Years 1 MonthsCurrent
Jayantilal PatelDirector02 Feb 200719 Years 9 MonthsCurrent
Kirit Chimanbhai Tulsibhai PatelDirector26 Oct 20188 Years 0 MonthsCurrent
Jayesh Jitendra ParikhDirector01 Feb 201115 Years 9 MonthsCurrent
Jayanti Chimanbhai PatelDirector26 Oct 20188 Years 0 MonthsCurrent

Peer comparison

Dofort Pharma Private Limited is compared with the 10 companies closest to it by revenue in the BFSI industry (Real Estate Leasing), from the latest filed financials of each company.

CompanyRevenueNet profitMarginGrowth (1 yr)EmployeesLocation
SSN Garments Private Limited₹72.96 Lakh (FY 2025)34.0%New Delhi, Delhi, India
Nalanda Consortium Schools Private Limited₹72.96 Lakh (FY 2024)Kodagu, Karnataka, India
Ashiana Properties & Industries Limited.₹72.92 Lakh (FY 2024)-25.0%Patna, Bihar, India
Singla Gateway Private Limited₹72.91 Lakh (FY 2025)5636.0%New Delhi, Delhi, India
Bhai Infotech Limited₹72.9 Lakh (FY 2025)-1.0%Chandigarh, India
Dofort Pharma Private Limitedthis company₹72.85 Lakh (FY 2025)₹17.96 Lakh24.6%7.0%Ahmedabad, Gujarat, India
Skystar Conclave Private Limited₹72.85 Lakh (FY 2025)-2.0%Kolkata, West Bengal, India
Ashu Engineers and Plastics Private Limited₹72.84 Lakh (FY 2025)-8.0%Mumbai, Maharashtra, India
Balasore Talkies Pvt Ltd₹72.81 Lakh (FY 2025)3.0%Balasore, Odisha, India
Fortune Exim Private Limited₹72.79 Lakh (FY 2025)260.0%Ahmedabad, Gujarat, India
White Comfort Hospitality Private Limited₹72.72 Lakh (FY 2025)-47.0%Noida, Uttar Pradesh, India

To see the full peer comparison of Dofort Pharma Private Limited, buy the company report.

Auditor

Dofort Pharma Private Limited is audited by G. K. Choksi & Co. for the financial year 2016.

Auditor firmFinancial yearFirm registration number
G. K. Choksi & Co.FY 2016

Shareholding

The shareholding of Dofort Pharma Private Limited is on record for FY 2016, split between promoters, domestic institutions, public shareholders and others.

Shareholder categoryFY 2016
Promoters
Domestic institutional investors (DII)
Public
Others

To see the full shareholding pattern of Dofort Pharma Private Limited, buy the company report.

MSME payment delays

No delayed payments to MSME suppliers are on our record for Dofort Pharma Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.

GST

Dofort Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
24AACCD4342D1Z8GujaratActive01 Jul 2017

To see the full GST registrations and return filing status of Dofort Pharma Private Limited, buy the company report.

Recent activity

Dofort Pharma Private Limited has 12 board changes on record since 2007: 5 appointments and 7 cessations. The latest: Rajan Priyakant Parikh was appointed as Director on 07 Oct 2019.

AGM
Dofort Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Dofort Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Ahmedabad.
Appointed
Rajan Priyakant Parikh was appointed as Director.
Ceased
Jayanti Chimanbhai Patel ceased to be Additional Director.
Ceased
Kirit Chimanbhai Tulsibhai Patel ceased to be Additional Director.
Ceased
Bhanubhai Gordhanbhai Patel ceased to be Director.
Appointed
Jayanti Chimanbhai Patel was appointed as Director.
Appointed
Kirit Chimanbhai Tulsibhai Patel was appointed as Director.
Ceased
Jayesh Jitendra Parikh ceased to be Additional Director.
Appointed
Jayesh Jitendra Parikh was appointed as Director.
Ceased
Pradyumnakumar Rajeshwar Patel ceased to be Director.
Ceased
Rajan Priyakant Parikh ceased to be Director.

3 earlier events are in the company report.

Frequently asked questions

Dofort Pharma is an active private limited company based in Ahmedabad, Gujarat, India. The company works in real estate financing, within the financial services industry. It was incorporated on 06 September 2006 (20+ years old) and is registered under CIN U24232GJ2006PTC049026.

Dofort Pharma has 5 current directors:

The latest financial statements of Dofort Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.

The GSTIN of Dofort Pharma is 24AACCD4342D1Z8, registered in Gujarat.

The CIN (Corporate Identification Number) of Dofort Pharma is U24232GJ2006PTC049026. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Dofort Pharma was incorporated on 06 September 2006, making it 20+ years old. It is registered with the Registrar of Companies, Ahmedabad.

The peers of Dofort Pharma by revenue are SSN Garments Private Limited, Nalanda Consortium Schools Private Limited, Ashiana Properties & Industries Limited, Singla Gateway Private Limited, Bhai Infotech Limited and 5 more, all in the BFSI industry (Real Estate Leasing).

Rajan Priyakant Parikh was appointed as Director on 07 Oct 2019. Jayanti Chimanbhai Patel ceased to be Additional Director on 28 Sep 2019. Kirit Chimanbhai Tulsibhai Patel ceased to be Additional Director on 28 Sep 2019. Dofort Pharma has 12 board changes on record in total.

The registered office of Dofort Pharma is at 501 5th Floor H. K. House Ashram Road Navrangpura, Ahmedabad, Gujarat, India – 380009.

Dofort Pharma operates in the financial services industry, in the real estate financing segment.

The compliance status of Dofort Pharma is compliant as of 25 August 2026. The company is actively filing with the Registrar of Companies.